Effects of a combined treatment with tamoxifen and estrogen receptor β agonists on human breast cancer cell lines

Archives of Gynecology and Obstetrics

Volumn 289, Issue 1, 2014, Pages 163-171

  Lattrich, Claus ^a   Schüler, Susanne ^a   Häring, Julia ^a   Skrzypczak, Maciej ^b   Ortmann, Olaf ^a   Treeck, Oliver ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Breast cancer cell line; Combined treatment; Estrogen receptor beta; Tamoxifen

Indexed keywords

AFIMOXIFENE; CALGRANULIN A; CD177 ANTIGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HORMONE RECEPTOR STIMULATING AGENT; LYMPHOCYTE ANTIGEN; PRINABEREL; TRANSCRIPTOME; UNCLASSIFIED DRUG; WAY 200070; ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CELL GROWTH; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOTHERAPY; AGONISTS; BREAST NEOPLASMS; CELL PROLIFERATION; DRUG COMBINATION; DRUG EFFECTS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MCF 7 CELL LINE; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG THERAPY, COMBINATION; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 84891855814     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-2977-7     Document Type: Article

References (26)

1. Cowley SM, Hoare S, Mosselman S, Parker MG (1997) Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem 272(32):19858-19862 (Pubitemid 27340081)
2. Treeck O, Lattrich C, Springwald A, Ortmann O (2010) Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells. Breast Cancer Res Treat 120(3):557-565. doi: 10.1007/s10549-009-0413-2
3. Speirs V, Carder PJ, Lane S, Dodwell D, Lansdown MR, Hanby AM (2004) Oestrogen receptor beta: what it means for patients with breast cancer. Lancet Oncol 5(3):174-181 (Pubitemid 38262850)
4. Younes M, Honma N (2011) Estrogen receptor beta. Arch Pathol Lab Med 135(1):63-66. doi: 10.1043/2010-0448-RAR.1
5. Harris HA, Albert LM, Leathurby Y, Malamas MS, Mewshaw RE, Miller CP, Kharode YP, Marzolf J, Komm BS, Winneker RC, Frail DE, Henderson RA, Zhu Y, Keith JC Jr (2003) Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology 144(10):4241-4249 (Pubitemid 37204818)
6. Harris HA (2006) Preclinical characterization of selective estrogen receptor beta agonists: new insights into their therapeutic potential. Ernst Schering Found Symp Proc 1:149-161
7. Malamas MS, Manas ES, McDevitt RE, Gunawan I, Xu ZB, Collini MD, Miller CP, Dinh T, Henderson RA, Keith JC Jr, Harris HA (2004) Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands. J Med Chem 47(21):5021-5040. doi: 10.1021/jm049719y (Pubitemid 39314900)
8. Charn TH, Liu ET, Chang EC, Lee YK, Katzenellenbogen JA, Katzenellenbogen BS (2010) Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection. Mol Endocrinol 24(1):47-59. doi: 10.1210/me.2009-0252
9. Lim YC, Desta Z, Flockhart DA, Skaar TC (2005) Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen. Cancer Chemother Pharmacol 55(5):471-478. doi: 10.1007/s00280-004-0926-7 (Pubitemid 40568978)
10. Kojetin DJ, Burris TP, Jensen EV, Khan SA (2008) Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptor. Endocr Relat Cancer 15(4):851-870. doi: 10.1677/ERC-07-0281
11. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402-408 (Pubitemid 34164012)
12. Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT, Maitland A, Mostafavi S, Montojo J, Shao Q, Wright G, Bader GD, Morris Q (2010) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38 (Web Server issue):W214-W220. doi: 10.1093/nar/gkq537
13. Hodges-Gallagher L, Valentine CD, El Bader S, Kushner PJ (2008) Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells. Breast Cancer Res Treat 109(2):241-250 (Pubitemid 351644839)
14. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC (2004) Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 64(1):423-428 (Pubitemid 38114127)
15. Treeck O, Juhasz-Boess I, Lattrich C, Horn F, Goerse R, Ortmann O (2008) Effects of exon-deleted estrogen receptor beta transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines. Breast Cancer Res Treat 110(3):507-520. doi: 10.1007/s10549-007-9749-7 (Pubitemid 351962596)
16. Sanchez M, Sauve K, Picard N, Tremblay A (2007) The hormonal response of estrogen receptor beta is decreased by the phosphatidylinositol 3-kinase/Akt pathway via a phosphorylation-dependent release of CREB-binding protein. J Biol Chem 282(7):4830-4840. doi: 10.1074/jbc.M607908200 (Pubitemid 47100990)
17. Rushton JJ, Davis LM, Lei W, Mo X, Leutz A, Ness SA (2003) Distinct changes in gene expression induced by A-Myb, B-Myb and c-Myb proteins. Oncogene 22(2):308-313. doi: 10.1038/sj.onc.1206131 (Pubitemid 36174188)
18. Maraqa L, Cummings M, Peter MB, Shaaban AM, Horgan K, Hanby AM, Speirs V (2008) Carcinoembryonic antigen cell adhesion molecule 6 predicts breast cancer recurrence following adjuvant tamoxifen. Clin Cancer Res Off J Am Assoc Cancer Res 14(2):405-411. doi: 10.1158/1078-0432.CCR-07-1363 (Pubitemid 351226107)
19. Dalerba P, Kalisky T, Sahoo D, Rajendran PS, Rothenberg ME, Leyrat AA, Sim S, Okamoto J, Johnston DM, Qian D, Zabala M, Bueno J, Neff NF, Wang J, Shelton AA, Visser B, Hisamori S, Shimono Y, van de Wetering M, Clevers H, Clarke MF, Quake SR (2011) Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat Biotechnol 29(12):1120-1127. doi: 10.1038/nbt.2038
20. McKiernan E, McDermott EW, Evoy D, Crown J, Duffy MJ (2011) The role of S100 genes in breast cancer progression. Tumour Biol J Int Soc Oncodev Biol Med 32(3):441-450. doi: 10.1007/s13277-010-0137-2
21. Montojo J, Zuberi K, Rodriguez H, Kazi F, Wright G, Donaldson SL, Morris Q, Bader GD (2010) GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop. Bioinformatics 26(22):2927-2928. doi: 10.1093/bioinformatics/ btq562
22. Mostafavi S, Ray D, Warde-Farley D, Grouios C, Morris Q (2008) GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function. Genome Biol 9(Suppl 1):S4. doi: 10.1186/gb-2008-9-s1-s4 (Pubitemid 352006138)
23. Wu G, Feng X, Stein L (2010) A human functional protein interaction network and its application to cancer data analysis. Genome Biol 11(5):R53. doi: 10.1186/gb-2010-11-5-r53
24. Zhou D, Quach KM, Yang C, Lee SY, Pohajdak B, Chen S (2000) PNRC: a proline-rich nuclear receptor coregulatory protein that modulates transcriptional activation of multiple nuclear receptors including orphan receptors SF1 (steroidogenic factor 1) and ERRalpha1 (estrogen related receptor alpha-1). Mol Endocrinol 14(7):986-998 (Pubitemid 32250516)
25. Tremblay A, Giguere V (2001) Contribution of steroid receptor coactivator-1 and CREB binding protein in ligand-independent activity of estrogen receptor beta. J Steroid Biochem Mol Biol 77(1):19-27 (Pubitemid 32457800)
26. Facchinetti V, Loffarelli L, Schreek S, Oelgeschlager M, Luscher B, Introna M, Golay J (1997) Regulatory domains of the A-Myb transcription factor and its interaction with the CBP/p300 adaptor molecules. Biochem J 324(Pt 3):729-736 (Pubitemid 27285529)